CD20

Pipeline Summary for Products Targeting CD20
Print this Phases of Development Discovery Preclinical Phase I Phase I/II Phase II Phase II/III Phase III Approved Marketed Autoimmune 1 0 0 2 2 0 3 0 1 Cancer 2 10 1 3 1 0 4 0 4 Inflammation 0 0 0 0 0 0 0 1 0 Transplant 0 0 0 0 1 1 0 0 0 Copyright ©2012 BioCentury Publications, Inc. All Rights Reserved